Islet Holdings, Inc. announced they would expand their business plan to pursue new medical technologies and products based around development, production, and sales of cannabidiol (CBD) oil. CBD is one of approximately 85 cannabinoids present in the Cannabis plant. A British study recently suggested that cultivation of Cannabis plants rich in Cannabidiol (CBD) and other phenolic substances would be useful for medicinal purposes in the treatment of certain inflammatory disorders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 42.6K | |
+43.25% | 6.3B | |
-15.08% | 4.44B | |
-6.70% | 3.27B | |
+5.47% | 3.16B | |
+0.76% | 2.58B | |
+47.75% | 1.96B | |
-5.08% | 1.73B | |
+2.05% | 1.68B | |
-7.08% | 1.63B |
- Stock Market
- Equities
- ISHI Stock
- News Islet Holdings, Inc.
- Islet Holdings, Inc. Announces Worldwide Exclusive Agreements Signed with Apollon Formularies, Inc. and Last Call Ventures, Inc. to Assist in Producing a Full Line of Flavored CBD and Hemp Oil Based Nutraceutical Products